FRT
43
5
AVGO
40
-7
NOV
40
-3
URI
43
-2
APA
39
2
HUM
31
-3
PVH
58
-4
HRL
48
-2
GRMN
64
-4
PCG
59
3
EXPE
81
-7
VRTX
54
-2
FLS
71
-2
SJM
23
2
VRSN
59
-3
RL
72
-3
TRV
40
-2
ROK
54
2
MU
35
-7
TDC
76
-10
FRT
43
5
AVGO
40
-7
NOV
40
-3
URI
43
-2
APA
39
2
HUM
31
-3
PVH
58
-4
HRL
48
-2
GRMN
64
-4
PCG
59
3
EXPE
81
-7
VRTX
54
-2
FLS
71
-2
SJM
23
2
VRSN
59
-3
RL
72
-3
TRV
40
-2
ROK
54
2
MU
35
-7
TDC
76
-10
Financhill
Back

electroCore 10K Form

Buy
70

ECOR
electroCore

Last Price:
13.62
Seasonality Move:
-8.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ECOR News And Ratings

See the #1 stock for the next 7 days that we like better than ECOR

ECOR Financial Statistics

Sales & Book Value

Annual Sales: $16.03M
Cash Flow: $-1.36M
Price / Cash Flow: 0
Annual Sales: $1.45
Price / Book: 9.29

Profitability

EPS (TTM): -1.77000
Net Income (TTM): $-12.69M
Gross Margin: $13.23M
Return on Equity: -144.52%
Return on Assets: -67.86%

electroCore Earnings Forecast

Key electroCore Financial Ratios

  • The Gross Profit Margin over the past 8 years for ECOR is 82.51%.
  • The Selling, General & Administrative Expenses for ECOR have been equal to 169.52% of Gross Profit Margin.
  • The Research & Development expenses have been 33.19% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ECOR is -117.49% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

electroCore Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ECOR
CUSIP: 28531P
Website: electrocore.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.12
Quick Ratio: 1.71

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ECOR Technical Analysis vs Fundamental Analysis

Buy
70
electroCore (ECOR) is a Buy

Is electroCore a Buy or a Sell?

  • electroCore stock is rated a Buy
    The current electroCore [ECOR] share price is $13.40. The Score for ECOR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.